Roche
RO.SW
#36
Rank
NZ$702.51 B
Marketcap
NZ$881.70
Share price
1.09%
Change (1 day)
52.54%
Change (1 year)

EPS for Roche (RO.SW)

EPS in 2025: NZ$36.28

According to Roche's latest financial reports the company's current EPS (TTM) is NZ$36.28. In 2025 the company made an earnings per share (EPS) of NZ$36.28 an increase over its 2024 EPS that were of NZ$20.42.

EPS history for Roche from 1998 to 2025

Annual EPS

Year EPS Change
2025NZ$36.2877.67%
2024NZ$20.42-32.84%
2023NZ$30.411.95%
2022NZ$29.83-6.29%
2021NZ$31.83-5.53%
2020NZ$33.6916.56%
2019NZ$28.9030.3%
2018NZ$22.1820.22%
2017NZ$18.45-5.81%
2016NZ$19.594.62%
2015NZ$18.72-5.13%
2014NZ$19.74-25.05%
2013NZ$26.3321.73%
2012NZ$21.633.82%
2011NZ$20.848.16%
2010NZ$19.2623.72%
2009NZ$15.57-12.31%
2008NZ$17.76-0.34%
2007NZ$17.8232.13%
2006NZ$13.4842.56%
2005NZ$9.46-22.7%
2004NZ$12.24132.85%
2003NZ$5.25-151.22%
2002NZ-$10.26-209.09%
2001NZ$9.40-57.03%
2000NZ$21.8953.29%
1999NZ$14.2831.24%
1998NZ$10.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.51-57.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.82-67.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.54-84.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.80-20.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38-90.69%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
NZ$6.39-82.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-93.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.68-84.35%๐Ÿ‡ฌ๐Ÿ‡ง UK